Clinical Trials · NCT03876015
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 215
- Start date
- May 2019
- Locations
- 31 sites, United Kingdom
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)